Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Comparative Evaluation Between the RealStar Pneumocystis jirovecii PCR Kit and the AmpliSens Pneumocystis jirovecii (carinii)-FRT PCR Kit for Detecting P. jirovecii in Non-HIV Immunocompromised Patients.

Huh HJ, Lim KR, Ki CS, Huh K, Shim HJ, Song DJ, Kim YJ, Chung DR, Lee NY.

Ann Lab Med. 2019 Mar;39(2):176-182. doi: 10.3343/alm.2019.39.2.176.

2.

SILAR deposited iron phosphate as a bifunctional electrocatalyst for efficient water splitting.

Babar PT, Lokhande AC, Shim HJ, Gang MG, Pawar BS, Pawar SM, Kim JH.

J Colloid Interface Sci. 2019 Jan 15;534:350-356. doi: 10.1016/j.jcis.2018.09.015. Epub 2018 Sep 6.

PMID:
30243176
3.
4.

Differential regulation of MyD88- and TRIF-dependent signaling pathways of Toll-like receptors by cardamonin.

Kim AY, Shim HJ, Kim SY, Heo S, Youn HS.

Int Immunopharmacol. 2018 Nov;64:1-9. doi: 10.1016/j.intimp.2018.08.018. Epub 2018 Aug 21.

PMID:
30142469
5.

Further Beneficial Effect of Hearing Aids on Speech Recognition Performance Besides Amplification: Importance of the Restoration of Symmetric Hearing.

Kwak MY, Kang YK, Kim DH, An YH, Shim HJ.

Otol Neurotol. 2018 Sep;39(8):e618-e626. doi: 10.1097/MAO.0000000000001928.

PMID:
30113555
6.

Facile, Room Temperature, Electroless Deposited (Fe1-x, Mnx )OOH Nanosheets as Advanced Catalysts: The Role of Mn Incorporation.

Suryawanshi MP, Ghorpade UV, Shin SW, Suryawanshi UP, Shim HJ, Kang SH, Kim JH.

Small. 2018 Jul;14(30):e1801226. doi: 10.1002/smll.201801226. Epub 2018 Jul 2.

PMID:
29966042
7.

Epidemiology of Clinically Significant Tinnitus: A 10-Year Trend From Nationwide Health Claims Data in South Korea.

Lee HM, Han KD, Kong SK, Nam EC, Park SN, Shim HJ, Byun JY, Park HJ, Im GJ, Lee IW.

Otol Neurotol. 2018 Jul;39(6):680-687. doi: 10.1097/MAO.0000000000001832.

PMID:
29879090
8.

Prevalence and predictors of major depressive disorder in bereaved caregivers at 6 and 13 months.

Kim SY, Kim SJ, Kim JM, Kim SW, Shin IS, Shim HJ, Cho SH, Chung IJ, Yoon JS.

Palliat Support Care. 2018 May 28:1-6. doi: 10.1017/S1478951518000366. [Epub ahead of print]

PMID:
29806573
9.

p16 as a prognostic factor for the response to induction chemotherapy in advanced hypopharyngeal squamous cell carcinoma.

Lee JK, Lee KH, Kim SA, Kweon SS, Cho SH, Shim HJ, Bae WK, Chung IJ, Chung WK, Yoon TM, Lim SC, Lee DH.

Oncol Lett. 2018 May;15(5):6571-6577. doi: 10.3892/ol.2018.8138. Epub 2018 Mar 1.

10.

Mouse fMRI under ketamine and xylazine anesthesia: Robust contralateral somatosensory cortex activation in response to forepaw stimulation.

Shim HJ, Jung WB, Schlegel F, Lee J, Kim S, Lee J, Kim SG.

Neuroimage. 2018 Aug 15;177:30-44. doi: 10.1016/j.neuroimage.2018.04.062. Epub 2018 May 4.

PMID:
29730495
11.

Priorities of a "good death" according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey.

Yun YH, Kim KN, Sim JA, Kang E, Lee J, Choo J, Yoo SH, Kim M, Kim YA, Kang BD, Shim HJ, Song EK, Kang JH, Kwon JH, Lee JL, Lee SN, Maeng CH, Kang EJ, Do YR, Choi YS, Jung KH.

Support Care Cancer. 2018 Oct;26(10):3479-3488. doi: 10.1007/s00520-018-4209-y. Epub 2018 Apr 22.

PMID:
29682690
12.

Attitudes toward early palliative care in cancer patients and caregivers: a Korean nationwide survey.

Yoo SH, Kim M, Yun YH, Keam B, Kim YA, Kim YJ, Shim HJ, Song EK, Kang JH, Kwon JH, Lee JL, Lee SN, Kim SY, Kang EJ, Do YR, Choi YS, Jung KH.

Cancer Med. 2018 May;7(5):1784-1793. doi: 10.1002/cam4.1441. Epub 2018 Mar 25.

13.

Absorption, metabolism, and excretion of [14C]evogliptin tartrate in male rats and dogs.

Lee DY, Kim JH, Shim HJ, Jeong HU, Lee HS.

J Toxicol Environ Health A. 2018;81(11):453-464. doi: 10.1080/15287394.2018.1451194. Epub 2018 Mar 20.

PMID:
29557727
14.

Andrographolide suppresses TRIF-dependent signaling of toll-like receptors by targeting TBK1.

Kim AY, Shim HJ, Shin HM, Lee YJ, Nam H, Kim SY, Youn HS.

Int Immunopharmacol. 2018 Apr;57:172-180. doi: 10.1016/j.intimp.2018.02.019.

PMID:
29518743
15.

Performance evaluation of the QMAC-dRAST for staphylococci and enterococci isolated from blood culture: a comparative study of performance with the VITEK-2 system.

Huh HJ, Song DJ, Shim HJ, Kwon WK, Park MS, Ryu MR, Cho EH, Oh J, Yoo IY, Lee NY.

J Antimicrob Chemother. 2018 May 1;73(5):1267-1271. doi: 10.1093/jac/dky015.

PMID:
29415214
16.

Comparisons of auditory brainstem response and sound level tolerance in tinnitus ears and non-tinnitus ears in unilateral tinnitus patients with normal audiograms.

Shim HJ, An YH, Kim DH, Yoon JE, Yoon JH.

PLoS One. 2017 Dec 18;12(12):e0189157. doi: 10.1371/journal.pone.0189157. eCollection 2017.

17.

TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma.

Bae WK, Hong CS, Park MR, Sun EG, Lee JH, Kang K, Ryu KH, Shim HJ, Hwang JE, Cho SH, Chung IJ.

Cancer Lett. 2018 Feb 28;415:106-116. doi: 10.1016/j.canlet.2017.12.002. Epub 2017 Dec 6.

PMID:
29222041
18.

Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features.

Moon KR, Choi YD, Kim JM, Jin S, Shin MH, Shim HJ, Lee JB, Yun SJ.

J Invest Dermatol. 2018 Apr;138(4):933-945. doi: 10.1016/j.jid.2017.11.017. Epub 2017 Nov 27.

PMID:
29191620
19.

Resistance mechanisms of linezolid-nonsusceptible enterococci in Korea: low rate of 23S rRNA mutations in Enterococcus faecium.

Lee SM, Huh HJ, Song DJ, Shim HJ, Park KS, Kang CI, Ki CS, Lee NY.

J Med Microbiol. 2017 Dec;66(12):1730-1735. doi: 10.1099/jmm.0.000637. Epub 2017 Nov 7.

PMID:
29111969
20.

The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysis.

Hwang JE, Ki MS, Kim K, Jung SH, Shim HJ, Bae WK, Hwang EC, Hur YH, Jeong O, Ryu SY, Park YK, Cho SH, Lee JS, Chung IJ.

Oncotarget. 2017 Mar 16;8(39):66559-66568. doi: 10.18632/oncotarget.16301. eCollection 2017 Sep 12.

21.

Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin.

Lee EY, Gong EY, Shin JS, Moon JH, Shim HJ, Kim SM, Lee S, Jeong J, Gong JH, Kim MJ, Lee DH, Park YS, Shin J, Hong SW, Kim YS, Jin DH.

Toxicol In Vitro. 2018 Feb;46:229-236. doi: 10.1016/j.tiv.2017.09.023. Epub 2017 Sep 23.

PMID:
28947240
22.

The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.

Kim KR, Shim HJ, Hwang JE, Cho SH, Chung IJ, Park KS, Kang SR, Kwon SY, Chung WK, Bae WK.

Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):170-178. doi: 10.1007/s00259-017-3836-8. Epub 2017 Sep 22.

23.

Wearable Electrocardiogram Monitor Using Carbon Nanotube Electronics and Color-Tunable Organic Light-Emitting Diodes.

Koo JH, Jeong S, Shim HJ, Son D, Kim J, Kim DC, Choi S, Hong JI, Kim DH.

ACS Nano. 2017 Oct 24;11(10):10032-10041. doi: 10.1021/acsnano.7b04292. Epub 2017 Aug 28.

PMID:
28837773
24.

Ultrathin Quantum Dot Display Integrated with Wearable Electronics.

Kim J, Shim HJ, Yang J, Choi MK, Kim DC, Kim J, Hyeon T, Kim DH.

Adv Mater. 2017 Oct;29(38). doi: 10.1002/adma.201700217. Epub 2017 Aug 21.

PMID:
28833644
25.

Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancer.

Kim KR, Yoon JH, Shim HJ, Hwang JE, Bae WK, Chung IJ, Kim HN, Shin MH, Cho SH.

Oncol Lett. 2017 Aug;14(2):2491-2498. doi: 10.3892/ol.2017.6414. Epub 2017 Jun 19.

26.

The Correlation Between Cage Subsidence, Bone Mineral Density, and Clinical Results in Posterior Lumbar Interbody Fusion.

Oh KW, Lee JH, Lee JH, Lee DY, Shim HJ.

Clin Spine Surg. 2017 Jul;30(6):E683-E689. doi: 10.1097/BSD.0000000000000315.

PMID:
28632554
27.

Biliary stone removal through the percutaneous transhepatic biliary drainage route, focusing on the balloon sphincteroplasty flushing technique: a single center study with 916 patients.

Shin JS, Shim HJ, Kwak BK, Yoon HK.

Jpn J Radiol. 2017 Aug;35(8):440-447. doi: 10.1007/s11604-017-0651-x. Epub 2017 Jun 6.

PMID:
28589507
28.

In vitro evaluation of potential transporter-mediated drug interactions of evogliptin.

Lee DY, Chae HW, Shim HJ.

Biopharm Drug Dispos. 2017 Sep;38(6):398-403. doi: 10.1002/bdd.2083. Epub 2017 Jul 13.

PMID:
28503751
29.

The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation.

Shim HJ, Kim HI, Lee ST.

Oncol Lett. 2017 Mar;13(3):1463-1469. doi: 10.3892/ol.2017.5564. Epub 2017 Jan 2.

30.

Initiation of Drosophila chorion gene amplification requires Claspin and mus101, whereas Claspin, but not mus101, plays a major role during elongation.

Choi SH, Park JH, Nguyen TTN, Shim HJ, Song YH.

Dev Dyn. 2017 Jun;246(6):466-474. doi: 10.1002/dvdy.24499. Epub 2017 Apr 11.

31.

PTK6 Localized at the Plasma Membrane Promotes Cell Proliferation and MigratiOn Through Phosphorylation of Eps8.

Shin WS, Shim HJ, Lee YH, Pyo M, Park JS, Ahn SY, Lee ST.

J Cell Biochem. 2017 Sep;118(9):2887-2895. doi: 10.1002/jcb.25939. Epub 2017 May 15.

PMID:
28214294
32.

Comparison of Long-Term Outcome of Intratympanic Dexamethasone Therapy between Acute Noise-Induced Tinnitus and Acute Idiopathic Tinnitus.

Shim HJ, Lee ES, An YH, Kim DH.

J Int Adv Otol. 2017 Apr;13(1):53-60. doi: 10.5152/iao.2016.2632. Epub 2017 Jan 13.

33.

Neuroglial Choristoma of the Middle Ear with Massive Tympanosclerosis: A Case Report and Literature Review.

Shim HJ, Kang YK, An YH, Hong YO.

J Audiol Otol. 2016 Dec;20(3):179-182. Epub 2016 Nov 30.

34.

FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition.

Cho SH, Hong CS, Kim HN, Shin MH, Kim KR, Shim HJ, Hwang JE, Bae WK, Chung IJ.

Cancer Res Treat. 2017 Jul;49(3):766-777. doi: 10.4143/crt.2016.457. Epub 2016 Nov 9.

35.

Association between the TCF7L2 polymorphism and colorectal cancer does not differ by diabetes and obesity statuses.

Shim HJ, Lee R, Shin MH, Kim HN, Kweon SS.

Cancer Epidemiol. 2016 Dec;45:108-111. doi: 10.1016/j.canep.2016.10.012. Epub 2016 Oct 25.

PMID:
27792933
36.

Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer.

Jeong JU, Nam TK, Kim HR, Shim HJ, Kim YH, Yoon MS, Song JY, Ahn SJ, Chung WK.

Radiat Oncol. 2016 Sep 5;11(1):114. doi: 10.1186/s13014-016-0692-9.

37.

Four New Dicaffeoylquinic Acid Derivatives from Glasswort (Salicornia herbacea L.) and Their Antioxidative Activity.

Cho JY, Kim JY, Lee YG, Lee HJ, Shim HJ, Lee JH, Kim SJ, Ham KS, Moon JH.

Molecules. 2016 Aug 20;21(8). pii: E1097. doi: 10.3390/molecules21081097.

38.

Suppression of Toll-Like Receptor 4 Dimerization by 1-[5-Methoxy-2-(2-nitrovinyl)phenyl]pyrrolidine.

Ahn SI, Kim JS, Gu GJ, Shin HM, Kim AY, Shim HJ, Kim YJ, Koh KO, Mang JY, Kim DY, Youn HS.

Arch Pharm (Weinheim). 2016 Oct;349(10):785-790. doi: 10.1002/ardp.201600159. Epub 2016 Aug 12.

PMID:
27515124
39.

Comparison of fusion rate and clinical results between CaO-SiO2-P2O5-B2O3 bioactive glass ceramics spacer with titanium cages in posterior lumbar interbody fusion.

Lee JH, Kong CB, Yang JJ, Shim HJ, Koo KH, Kim J, Lee CK, Chang BS.

Spine J. 2016 Nov;16(11):1367-1376. doi: 10.1016/j.spinee.2016.07.531. Epub 2016 Aug 3.

40.

Effect of the allelic variants of ABCB1, CYP2D6 and HTR3B on response of ramosetron to prevent chemotherapy-induced nausea and vomiting in Korean cancer patients.

Kang G, Kim KR, Shim HJ, Hwang JE, Bae WK, Chung IJ, Kim HN, Lee J, Choi K, Shin HY, Kim JK, Jeong SW, Cho SH.

Asia Pac J Clin Oncol. 2017 Feb;13(1):53-60. doi: 10.1111/ajco.12575. Epub 2016 Aug 4.

PMID:
27488933
41.

Pulmonary thromboembolism in patient with coexistence of Behçet's disease and antiphospholipid syndrome.

Kim JH, Lee KA, Jung MY, Kim AR, Yoon JM, Shim HJ, Lee SH, Kim HY, Kim HR.

Int J Rheum Dis. 2016 Jul 26. doi: 10.1111/1756-185X.12923. [Epub ahead of print]

PMID:
27457028
42.

A translocator protein 18 kDa ligand, Ro5-4864, inhibits ATP-induced NLRP3 inflammasome activation.

Lee JW, Kim LE, Shim HJ, Kim EK, Hwang WC, Min DS, Yu SW.

Biochem Biophys Res Commun. 2016 Jun 3;474(3):587-593. doi: 10.1016/j.bbrc.2016.04.080. Epub 2016 Apr 19.

PMID:
27103438
43.

Suppression of TLRs signaling pathways by 1-[5-methoxy-2-(2-nitrovinyl)phenyl]pyrrolidine.

Ahn SI, Kim JS, Shin HM, Kim AY, Gu GJ, Shim HJ, Kim YJ, Koh KO, Mang JY, Kim DY, Youn HS.

Int Immunopharmacol. 2016 Jun;35:193-200. doi: 10.1016/j.intimp.2016.03.042. Epub 2016 Apr 16.

PMID:
27064546
44.

Extracts from Dendropanax morbifera Leaves Have Modulatory Effects on Neuroinflammation in Microglia.

Shim HJ, Park S, Lee JW, Park HJ, Baek SH, Kim EK, Yu SW.

Am J Chin Med. 2016;44(1):119-32. doi: 10.1142/S0192415X16500087.

PMID:
26916918
45.

A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.

Shim HJ, Kim KR, Hwang JE, Bae WK, Ryu SY, Park YK, Nam TK, Chung IJ, Cho SH.

Cancer Chemother Pharmacol. 2016 Mar;77(3):605-12. doi: 10.1007/s00280-016-2973-2. Epub 2016 Feb 5.

PMID:
26846507
46.

Feasibility and Safety of Transcutaneous Vagus Nerve Stimulation Paired with Notched Music Therapy for the Treatment of Chronic Tinnitus.

Shim HJ, Kwak MY, An YH, Kim DH, Kim YJ, Kim HJ.

J Audiol Otol. 2015 Dec;19(3):159-67. doi: 10.7874/jao.2015.19.3.159. Epub 2015 Dec 18.

47.

A wearable multiplexed silicon nonvolatile memory array using nanocrystal charge confinement.

Kim J, Son D, Lee M, Song C, Song JK, Koo JH, Lee DJ, Shim HJ, Kim JH, Lee M, Hyeon T, Kim DH.

Sci Adv. 2016 Jan 1;2(1):e1501101. doi: 10.1126/sciadv.1501101. eCollection 2016 Jan.

48.

In Vitro Metabolic Pathways of the New Anti-Diabetic Drug Evogliptin in Human Liver Preparations.

Jeong HU, Kim JH, Lee DY, Shim HJ, Lee HS.

Molecules. 2015 Dec 4;20(12):21802-15. doi: 10.3390/molecules201219808.

49.

Thirdhand smoke: Chemical dynamics, cytotoxicity, and genotoxicity in outdoor and indoor environments.

Bahl V, Shim HJ, Jacob P 3rd, Dias K, Schick SF, Talbot P.

Toxicol In Vitro. 2016 Apr;32:220-31. doi: 10.1016/j.tiv.2015.12.007. Epub 2015 Dec 10.

50.

A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site.

Shin DY, Choi YH, Lee HR, Na II, Yuh YJ, Kim BS, Chung IJ, Bae WK, Shim HJ, Song EK, Yang SH, Kang HJ.

Cancer Chemother Pharmacol. 2016 Jan;77(1):163-8. doi: 10.1007/s00280-015-2904-7. Epub 2015 Nov 20.

PMID:
26589790

Supplemental Content

Support Center